Common name
butan-1-ol
IUPAC name
butan-1-ol
SMILES
C(CC)CO
Common name
butan-1-ol
IUPAC name
butan-1-ol
SMILES
C(CC)CO
INCHI
InChI=1S/C4H10O/c1-2-3-4-5/h5H,2-4H2,1H3
FORMULA
C4H10O
Common name
butan-1-ol
IUPAC name
butan-1-ol
Molecular weight
74.122
clogP
0.437
clogS
-0.772
Frequency
0.0134
HBond Acceptor
1
HBond Donor
1
Total PolarSurface Area
20.23
Number of Rings
0
Rotatable Bond
2
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD01741 | Limaprost |
|
; | Limaprost is used for the improvement of various ischemic symptoms such as ulcer, pain and feeling of coldness associated with thromboangiitis obliterans as well as improvement of subjective symptoms (pain and numbness of lower legs) and gait ability associated with acquired lumbar spinal canal stenosis (in patients with bilateral intermittent claudication showing normal SLR test result). |
| FDBD01818 | Pramocaine |
|
Dermatologicals; Cardiovascular System; Local Anesthetics; Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use; Vasoprotectives; Anesthetics for Topical Use; Antipruritics, Incl. Antihistamines, Anesthetics, Etc.; | |
| FDBD01822 | Piperonyl butoxide |
|
Pesticide Synergists; | For the treatment of head, pubic (crab), and body lice. |
| FDBD01831 | Selexipag |
|
Antihypertensive Agents; Antithrombotic Agents; Blood and Blood Forming Organs; Platelet Aggregation Inhibitors Excl. Heparin; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C8 Inducers; CYP3A4 Inhibitors; | Selexipag is indicated for the treatment of pulmonary arterial hypertension (PAH) to delay disease progression and reduce risk of hospitalization. |
| FDBD01985 | epofenonane |
|
Insecticide | Insecticide |
| FDBD02409 | butachlor |
|
Herbicide | Herbicide |
| FDBD02422 | terbuchlor |
|
Herbicide | Herbicide |
| FDBD02956 | trichlamide |
|
Fungicide | Fungicide |
| FDBD03173 | izopamfos |
|
Fungicide | Fungicide |
39 ,
4
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 1esz_ligand_3_28.mol2 | 1esz | 1 | -6.36 | C(C)(CCO)C | 6 |
| 1fbm_ligand_3_19.mol2 | 1fbm | 1 | -6.22 | C(O)CC(C)C | 6 |
| 4f7n_ligand_3_25.mol2 | 4f7n | 1 | -6.13 | C(O)CCC | 5 |
| 1esz_ligand_2_9.mol2 | 1esz | 1 | -6.05 | C(C)CCO | 5 |
| 3egt_ligand_4_315.mol2 | 3egt | 1 | -5.99 | CCCCO | 5 |
| 4h5e_ligand_3_19.mol2 | 4h5e | 1 | -5.99 | OCCC(C)C | 6 |
| 3dzt_ligand_3_235.mol2 | 3dzt | 1 | -5.98 | CCCCO | 5 |
269 ,
27
